Sjöstrand M - Search Results

1

Neuroendocrine mechanisms in insulin resistance.

Sjöstrand M, Eriksson JW. Sjöstrand M, et al. Mol Cell Endocrinol. 2009 Jan 15;297(1-2):104-11. doi: 10.1016/j.mce.2008.05.010. Epub 2008 May 27. Mol Cell Endocrinol. 2009. PMID: 18599191 Review.

2

Atropine improves insulin sensitivity in both lean and abdominally obese subjects.

Svensson MK, Jansson PA, Persson AL, Sjöstrand M, Eriksson JW. Svensson MK, et al. Among authors: sjostrand m. J Clin Endocrinol Metab. 2011 Nov;96(11):E1843-7. doi: 10.1210/jc.2011-0669. Epub 2011 Aug 24. J Clin Endocrinol Metab. 2011. PMID: 21865364 Clinical Trial.

3

Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve.

Sjostrand M, Carlson K, Arnqvist HJ, Gudbjörnsdottir S, Landin-Olsson M, Lindmark S, Nyström L, Svensson MK, Eriksson JW, Bolinder J. Sjostrand M, et al. J Intern Med. 2014 Jan;275(1):39-48. doi: 10.1111/joim.12116. J Intern Med. 2014. PMID: 24482829 Free article.

4

Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed meal.

Sjöstrand M, Jansson PA, Palming J, de Schoolmeester J, Gill D, Rees A, Sjögren L, Persson T, Eriksson JW. Sjöstrand M, et al. Horm Metab Res. 2010 Oct;42(11):798-802. doi: 10.1055/s-0030-1254134. Epub 2010 May 31. Horm Metab Res. 2010. PMID: 20514603

5

Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp.

Sjöstrand M, Ericsson H, Hartford M, Norjavaara E, Eriksson JW. Sjöstrand M, et al. Diabetes Obes Metab. 2013 Jan;15(1):35-41. doi: 10.1111/j.1463-1326.2012.01672.x. Epub 2012 Sep 9. Diabetes Obes Metab. 2013. PMID: 22958202 Clinical Trial.

6

Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice.

Morentin Gutierrez P, Gyte A, deSchoolmeester J, Ceuppens P, Swales J, Stacey C, Eriksson JW, Sjöstrand M, Nilsson C, Leighton B. Morentin Gutierrez P, et al. Among authors: sjostrand m. Br J Pharmacol. 2015 Oct;172(20):4806-16. doi: 10.1111/bph.13251. Epub 2015 Oct 8. Br J Pharmacol. 2015. PMID: 26218540 Free PMC article. Clinical Trial.

7

Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects.

Sjöstrand M, Gudbjörnsdottir S, Holmäng A, Strindberg L, Ekberg K, Lönnroth P. Sjöstrand M, et al. J Clin Endocrinol Metab. 2002 May;87(5):2206-11. doi: 10.1210/jcem.87.5.8495. J Clin Endocrinol Metab. 2002. PMID: 11994365

8

Decreased muscle capillary permeability surface area in type 2 diabetic subjects.

Gudbjörnsdóttir S, Sjöstrand M, Strindberg L, Lönnroth P. Gudbjörnsdóttir S, et al. Among authors: sjostrand m. J Clin Endocrinol Metab. 2005 Feb;90(2):1078-82. doi: 10.1210/jc.2004-0947. Epub 2004 Nov 9. J Clin Endocrinol Metab. 2005. PMID: 15536160

9

Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle.

Gudbjörnsdóttir S, Sjöstrand M, Strindberg L, Wahren J, Lönnroth P. Gudbjörnsdóttir S, et al. Among authors: sjostrand m. J Clin Endocrinol Metab. 2003 Oct;88(10):4559-64. doi: 10.1210/jc.2003-030434. J Clin Endocrinol Metab. 2003. PMID: 14557422 Clinical Trial.

10

Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects.

Sjöstrand M, Holmäng A, Strindberg L, Lönnroth P. Sjöstrand M, et al. Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1097-103. doi: 10.1152/ajpendo.2000.279.5.E1097. Am J Physiol Endocrinol Metab. 2000. PMID: 11052965 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page